Oakhurst, NJ, United States of America

Patrick G Pollard


Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
2 patents (USPTO):

Title: Innovations by Inventor Patrick G. Pollard

Introduction

Patrick G. Pollard is a notable inventor based in Oakhurst, NJ, USA. With a focus on advancements in pharmaceutical compounds, he holds two patents related to melanocortin-4 receptor agonists, which provide significant therapeutic benefits in treating various health conditions.

Latest Patents

Patrick's latest patents include two innovative formulations targeting the melanocortin-4 receptor (MC-4R). The first patent, titled "Acylated piperazine derivatives as melanocortin-4 receptor agonists," describes novel N-acylated piperazine derivatives that are selective agonists of MC-4R. These derivatives are promising for the treatment, control, or prevention of diseases linked to MC-4R activation, such as obesity, diabetes, and sexual dysfunction including erectile dysfunction and female sexual dysfunction.

The second patent is titled "Substituted piperidines as melanocortin receptor agonists." It details certain novel substituted piperidine compounds that also serve as selective agonists of the human melanocortin receptor(s), particularly the MC-4R. Similar to the previous patent, these compounds aim to address obesity, diabetes, and sexual dysfunction in individuals.

Career Highlights

Patrick G. Pollard is currently employed at Merck & Company, Inc., a leading global healthcare company known for its innovative drug development. His research and contributions to the field of pharmacology underscore his dedication to improving patient outcomes through scientific advancements.

Collaborations

Throughout his career, Patrick has collaborated with esteemed colleagues, including Liangqin Guo and Ravi P. Nargund. These connections highlight the importance of teamwork in the innovation process, allowing for the sharing of ideas and expertise to drive research forward.

Conclusion

In conclusion, Patrick G. Pollard's work as an inventor, particularly in the field of melanocortin-4 receptor agonists, demonstrates the impactful nature of his research on public health. His patents not only signify his contribution to the scientific community but also hold the potential to significantly improve the quality of life for individuals facing debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…